Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenz C Hofbauer

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
The New England Journal of Medicine|November 27, 2024
Building Bone while Making MilkLorenz C Hofbauer
Molecular Endocrinology (Baltimore, Md.)|May 30, 2009
Minireview: live and let die: molecular effects of glucocorticoids on bone cellsLorenz C Hofbauer, Martina Rauner
The New England Journal of Medicine|November 15, 2002
Osteoprotegerin deficiency and juvenile Paget's diseaseLorenz C Hofbauer, Michael Schoppet
Science Translational Medicine|July 12, 2013
Deconstructing vitamin D deficiencyLorenz C Hofbauer, Christine Hamann
The New England Journal of Medicine|April 25, 2009
More on reports of esophageal cancer with oral bisphosphonate useLorenz C Hofbauer, Stephan Miehlke
The Lancet. Diabetes & Endocrinology|April 11, 2018
Denosumab: a new treatment option for glucocorticoid-induced osteoporosisElena Tsourdi, Lorenz C Hofbauer
The Lancet. Diabetes & Endocrinology|July 11, 2017
Osteoporosis treatment: recent developments and ongoing challengesSundeep Khosla, Lorenz C Hofbauer
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular diseaseLorenz C Hofbauer, Michael Schoppet
The Journal of Clinical Endocrinology and Metabolism|March 29, 2024
Denosumab-Protection for Bone and Beyond?Lorenz C Hofbauer, Martina Rauner
JAMA|July 29, 2004
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseasesLorenz C Hofbauer, Michael Schoppet
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
The New England Journal of Medicine|November 27, 2024
Building Bone while Making MilkLorenz C Hofbauer
Molecular Endocrinology (Baltimore, Md.)|May 30, 2009
Minireview: live and let die: molecular effects of glucocorticoids on bone cellsLorenz C Hofbauer, Martina Rauner
The New England Journal of Medicine|November 15, 2002
Osteoprotegerin deficiency and juvenile Paget's diseaseLorenz C Hofbauer, Michael Schoppet
Science Translational Medicine|July 12, 2013
Deconstructing vitamin D deficiencyLorenz C Hofbauer, Christine Hamann
The New England Journal of Medicine|April 25, 2009
More on reports of esophageal cancer with oral bisphosphonate useLorenz C Hofbauer, Stephan Miehlke
The Lancet. Diabetes & Endocrinology|April 11, 2018
Denosumab: a new treatment option for glucocorticoid-induced osteoporosisElena Tsourdi, Lorenz C Hofbauer
The Lancet. Diabetes & Endocrinology|July 11, 2017
Osteoporosis treatment: recent developments and ongoing challengesSundeep Khosla, Lorenz C Hofbauer
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Osteoprotegerin gene polymorphism and the risk of osteoporosis and vascular diseaseLorenz C Hofbauer, Michael Schoppet
The Journal of Clinical Endocrinology and Metabolism|March 29, 2024
Denosumab-Protection for Bone and Beyond?Lorenz C Hofbauer, Martina Rauner
JAMA|July 29, 2004
Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseasesLorenz C Hofbauer, Michael Schoppet
Pageof 33